Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LYCOPODIUM LTD. | LW1 | Nov 15, 2024 | 6.20 | 0.00 |
LYCOS ENERGY INC. NEW | G4P0 | Nov 15, 2024 | 1.50 | -17.58 |
Lyft, Inc. - Class A | LY0 | Nov 15, 2024 | 17.29 | +3.11 |
Lynas Rare Earths Limited | LYI | Nov 15, 2024 | 4.30 | -0.97 |
Lynas Rare Earths Limited American Depositary Receipts - Spo | LYIC | Nov 15, 2024 | 4.24 | -8.62 |
LyondellBasell Industries NV Ordinary Shares Class A (Nether | DLY | Nov 15, 2024 | 78.10 | -0.64 |
Lytix Biopharma | 6BG | Nov 15, 2024 | 0.53 | -2.91 |
L`Oreal | LORA | Nov 15, 2024 | 65.50 | -0.76 |
M Vest Water | 7YA | Nov 15, 2024 | 0.75 | +4.93 |
M&C Saatchi | IZH | Nov 15, 2024 | 2.32 | +0.87 |
M&G | 7MP | Nov 15, 2024 | 2.33 | -0.34 |
M&T Bank Corporation | MTZ | Nov 15, 2024 | 200.30 | +0.30 |
M.P. Evans Group Plc | NYP | Nov 15, 2024 | 11.10 | 0.00 |
M/I Homes, Inc. | 4MI | Nov 15, 2024 | 145.45 | +0.76 |
M1 Kliniken AG | M12 | Nov 15, 2024 | 16.35 | -1.21 |
M3, Inc. | 4YC | Nov 15, 2024 | 7.35 | -2.65 |
MAANSHAN IRON | YM9A | Nov 15, 2024 | 0.13 | +5.65 |
Maat Pharma S.A. | 4RD | Nov 15, 2024 | 7.18 | -0.55 |
Mabion S.A. | 272 | Nov 15, 2024 | 2.50 | -2.91 |
Mabuchi Motor Co. Ltd. | V94 | Nov 15, 2024 | 13.30 | 0.00 |
Macarthur Minerals Ltd | MMLA | Nov 15, 2024 | 0.03 | +34.88 |
Macerich Company (The) | M6G | Nov 15, 2024 | 17.86 | +0.17 |
MacFarlane Group plc | 5K6 | Nov 15, 2024 | 1.24 | -0.80 |
Mack-Cali Realty Corporation | WY4 | Nov 15, 2024 | 17.20 | -0.58 |
MACOM Technology Solutions Holdings, Inc. | 1MA | Nov 15, 2024 | 116.00 | -3.33 |
MACQUARIE GROUP ADR 1 | 4M42 | Nov 15, 2024 | 136.00 | +1.49 |
Macquarie Group Ltd Ordinary shares (Australia) | 4M4 | Nov 15, 2024 | 138.80 | -0.54 |
MacroGenics, Inc. | M55 | Nov 15, 2024 | 3.55 | +3.02 |
Macromill, Inc. | MA5 | Nov 15, 2024 | 6.20 | +10.71 |
Macy`s Inc | FDO | Nov 15, 2024 | 14.63 | +1.84 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.